About Shalby Limited
Data last updated: 17 December 2025
Shalby Limited is a public limited company based in Ahmedabad, Gujarat, India. It specialises in hospital and clinical services, a part of the broader healthcare sector. Incorporated on 30 August 2004, the company has been in operation for over 22 years.
Registered with ROC Ahmedabad under CIN L85110GJ2004PLC044667. Listed on BSE: 540797 and NSE: SHALBY.
Capital: an authorised share capital of ₹117.75 Cr and a paid-up capital of ₹107.41 Cr. Formerly known as Shalby Hospital Public Limited and Shalby Hospitals Limited. It is led by directors including Tej Ramjidass Malhotra and Umesh Krishnankutty Menon.
Last AGM: 26 September 2024. Financial statements filed for year ended 31 March 2024. Office: Opp: Karnawati Club Sarkhej Gandhinagar Highway Nr.Prahladnagar Gardern, Ahmedabad, Gujarat, India – 380015.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,114.55 Cr, a growth of 17% compared to the previous year.
The company has a workforce of approximately 2,529 employees as per the latest available data. Its group structure includes 6 subsidiaries.
The company is associated with 3 brands - Shalby Academy, Shalby, Shalby Hospitals. As per MCA filings, the company has open charges of ₹556.27 Cr and satisfied charges of ₹299.5 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website shalby.org.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered AddressOpp: Karnawati Club Sarkhej Gandhinagar Highway Nr.Prahladnagar Gardern, Ahmedabad, Gujarat, India – 380015
-
IndustryHealthcare, Hospitals
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Shalby Limited
Shalby Limited has undergone 4 name changes throughout its history. The current legal name is Shalby Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Shalby Limited | Current |
| Shalby Hospital Public Limited | Previous |
| Shalby Hospitals Limited | Previous |
| Shalby Hospital Limited | Previous |
| Shalby Hospital Private Limited | Previous |
CIN History of Shalby Limited
Shalby Limited has one previous CIN (Corporate Identification Number): U85110GJ2004PLC044667. The current CIN is L85110GJ2004PLC044667, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L85110GJ2004PLC044667 | Current |
| U85110GJ2004PLC044667 | Previous |
Associated Brands with Shalby Limited
Shalby Limited operates multiple associated brands including Shalby Academy, Shalby, and Shalby Hospitals. These brands represent Shalby Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Offers medical education, training programs, and healthcare up-skilling for professionals. | shalbyacademy.com | |
| Delivers comprehensive home nursing care services. | shalbyhomecare.org | |
| Multi-specialty hospital services are delivered through a chain in India. | shalby.org |
Competitors & Alternatives of Shalby Limited
Brands and companies operating in the same space as Shalby Limited include KIMS Hospitals, Fortis Healthcare, Ujala Cygnus and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Multispeciality secondary and tertiary care is provided by hospital chains. | Secunderabad, India, India | 1999 |
|
|
Multi-specialty hospital services are provided across India by Fortis Healthcare. | Gurugram, India, India | 1996 |
|
|
A chain of multi-specialty hospitals is operated in India. | Delhi, India, India | 2011 |
|
|
Chain of multi-speciality hospitals | Chennai, India, India | 1999 |
|
|
Chain of multispecialty hospitals | Chennai, India, India | 1983 |
|
|
Multi-speciality hospitals are operated with diverse medical services in India. | Pune, India, India | 1994 |
|
|
A chain of multi-specialty hospitals is operated in India. | Bengaluru, India, India | 2000 |
|
|
A workforce development platform that provides online training and education programs, focusing on vocational skills and certification courses | Mumbai, India, India | 2009 |
|
|
Healthcare training and ambulance services are provided by Vivo Healthcare. | Gurugram, India, India | 2009 |
|
|
Provider of home nursing care and check up services | Mumbai, India, India | 2012 |
Business Activity of Shalby Limited
Shalby Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including hospital activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q1 | Hospital activities | ********* |
Auditor Details of Shalby Limited
Shalby Limited is audited by T R CHADHA & CO LLP (ICAI peer reviewed, certificate valid till 2028-09-30) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| T R CHADHA & CO LLP (ICAI peer reviewed, certificate valid till 2028-09-30) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Shalby Limited
Shalby Limited is currently managed by 11 directors, with 24 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Tej Ramjidass Malhotra
Also directs:
Macro Polymers Pvt Ltd, Meghmani Industries Limited
|
Director | 23 Feb 2017 | 9 Years 4 Months | Current |
| Umesh Krishnankutty Menon | Director | 20 Dec 2016 | 9 Years 6 Months | Current |
|
Ashok Ramprakash Bhatia
Also directs:
Onnext Advisors Llp, Zim Laboratories Limited.
|
Director | 23 Oct 2017 | 8 Years 8 Months | Current |
|
Vikram Indrajit Shah
Also directs:
Shalby Medtech Limited, Shalby Advanced Technologies India Private Limited, Uranus Medical Devices Limited and 3 more
|
Managing Director | 30 Aug 2004 | 21 Years 10 Months | Current |
|
Tushar Dineshchandra Shah
Also directs:
Hiya Consultancy Services Private Limited
|
Nodal Officer | 10 May 2021 | 5 Years 1 Months | Current |
| Vijay Kishanlal Kedia | Director | 18 Oct 2022 | 3 Years 8 Months | Current |
Financials of Shalby Limited FY 2026 filings available
Shalby Limited reported revenue of ₹1,141.43 Cr (up 5.01% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue from Operations | ₹1,141.43 Cr | ₹1,086.96 Cr | ₹933.75 Cr | ₹804.92 Cr | ₹698.95 Cr | ₹486.85 Cr |
| Other Income | ₹26.79 Cr | ₹27.6 Cr | ₹19.43 Cr | ₹22.52 Cr | ₹12.42 Cr | ₹17.37 Cr |
| Total Income | ₹1,168.22 Cr | ₹1,114.55 Cr | ₹953.17 Cr | ₹827.44 Cr | ₹711.37 Cr | ₹504.22 Cr |
| Cost of Materials Consumed | ₹64.8 Cr | ₹92.69 Cr | ₹31.97 Cr | ₹169.85 Cr | ₹132.83 Cr | ₹72.08 Cr |
| Purchases of Stock-in-Trade | ₹133.94 Cr | ₹103.92 Cr | ₹76.24 Cr | ₹72.27 Cr | ₹72.56 Cr | ₹52.8 Cr |
| Changes in Inventories | -₹47.44 Cr | -₹82 Cr | -₹44.64 Cr | -₹45.9 Cr | -₹30.97 Cr | ₹12.7 Lakh |
| Employee Benefit Expense | ₹188.29 Cr | ₹184.58 Cr | ₹155.44 Cr | ₹143.64 Cr | ₹118.41 Cr | ₹65.5 Cr |
| Finance Costs | ₹39 Cr | ₹38.71 Cr | ₹16.03 Cr | ₹9.13 Cr | ₹5.9 Cr | ₹6.36 Cr |
| Depreciation & Amortisation | ₹69.99 Cr | ₹65.76 Cr | ₹52.24 Cr | ₹48.09 Cr | ₹42.87 Cr | ₹36.02 Cr |
| Other Expenses | ₹659.08 Cr | ₹655.16 Cr | ₹537.7 Cr | ₹328.32 Cr | ₹286.18 Cr | ₹214.62 Cr |
| Total Expenses | ₹1,107.66 Cr | ₹1,058.82 Cr | ₹824.98 Cr | ₹725.4 Cr | ₹627.78 Cr | ₹447.5 Cr |
| Profit Before Exceptional Items & Tax | ₹60.56 Cr | ₹55.73 Cr | ₹128.19 Cr | ₹102.04 Cr | ₹83.58 Cr | ₹56.73 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | -₹4.44 Cr | ₹0 |
| Profit Before Tax | ₹60.56 Cr | ₹55.73 Cr | ₹128.19 Cr | ₹102.04 Cr | ₹79.15 Cr | ₹56.73 Cr |
| Total Tax Expense | ₹25.87 Cr | ₹53.81 Cr | ₹44.69 Cr | ₹34.37 Cr | ₹25.18 Cr | ₹29.14 Cr |
| Net Profit | ₹34.69 Cr | ₹1.92 Cr | ₹83.5 Cr | ₹67.68 Cr | ₹53.97 Cr | ₹27.59 Cr |
| attributable to Owners | ₹37.39 Cr | ₹6.22 Cr | - | ₹67.7 Cr | - | ₹27.59 Cr |
| attributable to NCI | -₹2.7 Cr | -₹4.3 Cr | - | -₹2.3 Lakh | - | -₹10,000 |
| Other Comprehensive Income | -₹24.73 Cr | -₹2.61 Cr | ₹64.28 Lakh | ₹1.13 Cr | ₹22.2 Lakh | ₹1.7 Lakh |
| Total Comprehensive Income | ₹9.95 Cr | -₹68.8 Lakh | ₹84.14 Cr | ₹68.8 Cr | ₹54.19 Cr | ₹27.6 Cr |
| EBITDA (computed) | ₹169.54 Cr | ₹160.2 Cr | ₹196.47 Cr | ₹159.26 Cr | ₹132.35 Cr | ₹99.11 Cr |
| Basic EPS | ₹3.23 | ₹0.00 | ₹7.78 | ₹6.31 | ₹5.00 | ₹2.55 |
| Diluted EPS | ₹3.23 | ₹0.00 | ₹7.77 | ₹6.27 | ₹5.00 | ₹2.55 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹1,839.13 Cr | ₹1,703.65 Cr | ₹1,607.53 Cr | ₹1,281.36 Cr |
| Non-current Assets | ₹1,119.8 Cr | ₹1,045.69 Cr | ₹1,055.28 Cr | ₹737.37 Cr |
| Current Assets | ₹719.33 Cr | ₹657.96 Cr | ₹552.25 Cr | ₹544 Cr |
| Property, Plant & Equipment | ₹922.3 Cr | ₹848.17 Cr | ₹839.59 Cr | ₹668.02 Cr |
| Inventories | ₹376.38 Cr | ₹319.21 Cr | ₹235.2 Cr | ₹185.4 Cr |
| Trade Receivables | ₹228.42 Cr | ₹175.21 Cr | ₹144.63 Cr | ₹106.36 Cr |
| Cash & Equivalents | ₹21.9 Cr | ₹34.79 Cr | ₹27.18 Cr | ₹12.24 Cr |
| Equity (Net Worth) | ₹1,005.69 Cr | ₹995.33 Cr | ₹1,007.79 Cr | ₹927.62 Cr |
| Equity Share Capital | ₹107.52 Cr | ₹107.49 Cr | ₹107.41 Cr | ₹107.31 Cr |
| Borrowings (Non-current) | ₹152.88 Cr | ₹136.67 Cr | ₹175.97 Cr | ₹101.57 Cr |
| Borrowings (Current) | ₹386.74 Cr | ₹290.05 Cr | ₹137.98 Cr | ₹78.94 Cr |
| Total Debt (computed) | ₹539.62 Cr | ₹426.72 Cr | ₹313.95 Cr | ₹180.5 Cr |
| Current Liabilities | ₹575.69 Cr | ₹455.32 Cr | ₹323.26 Cr | ₹194.38 Cr |
| Total Liabilities | ₹833.44 Cr | ₹708.33 Cr | ₹599.75 Cr | ₹353.75 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | -₹80,000 | -₹4.34 Cr | ₹19.6 Cr | ₹67.77 Cr | ₹18.89 Cr |
| Investing Cash Flow | -₹97.28 Cr | -₹35.64 Cr | ₹38.07 Cr | -₹61.06 Cr | -₹60.26 Cr |
| Financing Cash Flow | ₹84.41 Cr | ₹47.58 Cr | -₹150.69 Cr | -₹50.02 Cr | ₹90.46 Cr |
| Capital Expenditure | ₹149.05 Cr | ₹71.45 Cr | ₹47.11 Cr | ₹18.48 Cr | ₹75.37 Cr |
| Free Cash Flow (computed) | -₹149.05 Cr | -₹75.79 Cr | -₹27.51 Cr | ₹49.29 Cr | -₹56.48 Cr |
| Dividends Paid | ₹0 | ₹12.96 Cr | ₹12.96 Cr | ₹10.8 Cr | ₹10.8 Cr |
| Net Change in Cash | -₹12.88 Cr | ₹7.61 Cr | -₹93.02 Cr | -₹43.31 Cr | ₹49.09 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹287.45 Cr | ₹272.13 Cr | ₹285.43 Cr | ₹296.43 Cr | ₹264.89 Cr | ₹275.63 Cr | ₹267.54 Cr | ₹278.89 Cr | ₹244.23 Cr | ₹216.05 Cr | ₹237.98 Cr | ₹235.49 Cr |
| Other Income | ₹8.08 Cr | ₹7.23 Cr | ₹4.48 Cr | ₹7.01 Cr | ₹5.32 Cr | ₹5.42 Cr | ₹7.16 Cr | ₹9.7 Cr | ₹4.99 Cr | ₹4.52 Cr | ₹5.38 Cr | ₹4.53 Cr |
| Total Income | ₹295.52 Cr | ₹279.35 Cr | ₹289.91 Cr | ₹303.43 Cr | ₹270.21 Cr | ₹281.05 Cr | ₹274.7 Cr | ₹288.59 Cr | ₹249.22 Cr | ₹220.57 Cr | ₹243.37 Cr | ₹240.02 Cr |
| Cost of Materials Consumed | ₹14.95 Cr | ₹17.69 Cr | ₹16.71 Cr | ₹15.46 Cr | ₹22.31 Cr | ₹69.36 Cr | ₹66.33 Cr | ₹13.32 Cr | ₹7.78 Cr | ₹7.27 Cr | ₹48.91 Cr | ₹49.06 Cr |
| Purchases of Stock-in-Trade | ₹41.25 Cr | ₹32.13 Cr | ₹31.21 Cr | ₹29.34 Cr | ₹27.63 Cr | ₹28.72 Cr | ₹23.26 Cr | ₹24.3 Cr | ₹17.64 Cr | ₹19.13 Cr | ₹19.46 Cr | ₹20 Cr |
| Changes in Inventories | -₹12.71 Cr | -₹15.48 Cr | -₹12.64 Cr | -₹6.6 Cr | -₹13.49 Cr | -₹31.74 Cr | -₹23.85 Cr | -₹12.92 Cr | -₹8.72 Cr | -₹11.37 Cr | -₹16.18 Cr | -₹8.37 Cr |
| Employee Benefit Expense | ₹49.56 Cr | ₹47.02 Cr | ₹45.21 Cr | ₹46.51 Cr | ₹44.81 Cr | ₹47.82 Cr | ₹47.11 Cr | ₹44.85 Cr | ₹39.93 Cr | ₹37.76 Cr | ₹38.56 Cr | ₹39.2 Cr |
| Finance Costs | ₹9.34 Cr | ₹10.64 Cr | ₹9.65 Cr | ₹9.37 Cr | ₹10.67 Cr | ₹10.66 Cr | ₹9.26 Cr | ₹8.12 Cr | ₹6.47 Cr | ₹3.63 Cr | ₹3.17 Cr | ₹2.75 Cr |
| Depreciation & Amortisation | ₹18.49 Cr | ₹17.61 Cr | ₹17.37 Cr | ₹16.52 Cr | ₹16.23 Cr | ₹16.32 Cr | ₹16.84 Cr | ₹16.37 Cr | ₹15.6 Cr | ₹12.4 Cr | ₹12.3 Cr | ₹11.94 Cr |
| Other Expenses | ₹165.05 Cr | ₹160.52 Cr | ₹163.33 Cr | ₹170.18 Cr | ₹162.8 Cr | ₹127.56 Cr | ₹122.05 Cr | ₹164.13 Cr | ₹148.74 Cr | ₹120.94 Cr | ₹94.52 Cr | ₹92.46 Cr |
| Total Expenses | ₹285.92 Cr | ₹270.12 Cr | ₹270.83 Cr | ₹280.78 Cr | ₹270.95 Cr | ₹268.7 Cr | ₹260.99 Cr | ₹258.18 Cr | ₹227.44 Cr | ₹189.76 Cr | ₹200.74 Cr | ₹207.05 Cr |
| Profit Before Exceptional Items & Tax | ₹9.61 Cr | ₹9.23 Cr | ₹19.07 Cr | ₹22.65 Cr | -₹73.9 Lakh | ₹12.35 Cr | ₹13.7 Cr | ₹30.41 Cr | ₹21.78 Cr | ₹30.81 Cr | ₹42.63 Cr | ₹32.97 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹9.61 Cr | ₹9.23 Cr | ₹19.07 Cr | ₹22.65 Cr | -₹73.9 Lakh | ₹12.35 Cr | ₹13.7 Cr | ₹30.41 Cr | ₹21.78 Cr | ₹30.81 Cr | ₹42.63 Cr | ₹32.97 Cr |
| Total Tax Expense | -₹8.85 Cr | ₹7.95 Cr | ₹11.8 Cr | ₹14.98 Cr | ₹11.45 Cr | ₹15.34 Cr | ₹11.34 Cr | ₹15.67 Cr | ₹5.74 Cr | ₹11.75 Cr | ₹15.06 Cr | ₹12.15 Cr |
| Net Profit | ₹18.45 Cr | ₹1.28 Cr | ₹7.28 Cr | ₹7.68 Cr | -₹12.19 Cr | -₹2.99 Cr | ₹2.36 Cr | ₹14.74 Cr | ₹16.04 Cr | ₹19.06 Cr | ₹27.58 Cr | ₹20.82 Cr |
| attributable to Owners | ₹18.32 Cr | ₹1.76 Cr | ₹8.39 Cr | ₹8.92 Cr | -₹11.02 Cr | ₹0 | ₹3.39 Cr | - | - | ₹19.07 Cr | ₹27.58 Cr | ₹20.83 Cr |
| attributable to NCI | ₹13.6 Lakh | -₹48.77 Lakh | -₹1.11 Cr | -₹1.24 Cr | -₹1.17 Cr | ₹0 | -₹1.03 Cr | - | - | -₹70,000 | -₹50,000 | -₹90,000 |
| Other Comprehensive Income | -₹14.42 Cr | -₹2.81 Cr | -₹7.05 Cr | -₹45.9 Lakh | ₹36.5 Lakh | -₹2.75 Cr | -₹26.66 Lakh | ₹4.41 Lakh | ₹73.9 Lakh | ₹10,000 | -₹41.4 Lakh | ₹31.6 Lakh |
| Total Comprehensive Income | ₹4.04 Cr | -₹1.53 Cr | ₹23.1 Lakh | ₹7.22 Cr | -₹11.82 Cr | -₹5.74 Cr | ₹2.09 Cr | ₹14.78 Cr | ₹16.78 Cr | ₹19.07 Cr | ₹27.16 Cr | ₹21.13 Cr |
| EBITDA (computed) | ₹37.43 Cr | ₹37.48 Cr | ₹46.09 Cr | ₹48.55 Cr | ₹26.16 Cr | ₹39.33 Cr | ₹39.81 Cr | ₹54.91 Cr | ₹43.86 Cr | ₹46.85 Cr | ₹58.1 Cr | ₹47.66 Cr |
| Basic EPS | ₹1.72 | ₹0.12 | ₹0.68 | ₹0.71 | ₹0.00 | ₹-0.28 | ₹0.22 | ₹1.37 | ₹1.49 | ₹1.78 | ₹2.57 | ₹1.94 |
| Diluted EPS | ₹1.72 | ₹0.12 | ₹0.68 | ₹0.71 | ₹0.00 | ₹-0.28 | ₹0.22 | ₹1.37 | ₹1.49 | ₹1.78 | ₹2.57 | ₹1.94 |
| Segment · Q4 FY26 (latest quarter) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Healthcare Services | ₹247.23 Cr | ₹17.08 Cr | ₹1,264.97 Cr | ₹574.16 Cr |
| Manufacturing of Implants | ₹40.21 Cr | -₹7.47 Cr | -₹412.79 Cr | -₹420.64 Cr |
| Segment · FY 2026 (annual) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Healthcare Services | ₹1,010.14 Cr | ₹95.28 Cr | - | - |
| Manufacturing of Implants | ₹131.29 Cr | -₹34.72 Cr | - | - |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹898.56 Cr | ₹872.68 Cr | ₹829.68 Cr | ₹708.02 Cr | ₹647.16 Cr | ₹418.67 Cr | ₹483.89 Cr |
| Other Income | ₹24.86 Cr | ₹26.44 Cr | ₹20.7 Cr | ₹19.37 Cr | ₹12.64 Cr | ₹9.62 Cr | ₹17.74 Cr |
| Total Income | ₹923.41 Cr | ₹899.13 Cr | ₹850.39 Cr | ₹727.38 Cr | ₹659.8 Cr | ₹428.29 Cr | ₹501.63 Cr |
| Cost of Materials Consumed | ₹300.74 Cr | ₹212.39 Cr | ₹198.81 Cr | ₹176.83 Cr | ₹159.32 Cr | ₹87.1 Cr | ₹111.18 Cr |
| Purchases of Stock-in-Trade | ₹13.58 Cr | ₹11.82 Cr | ₹10.58 Cr | ₹9.15 Cr | ₹9.06 Cr | ₹6.85 Cr | ₹11.26 Cr |
| Changes in Inventories | -₹49.6 Lakh | -₹4.5 Lakh | -₹38.99 Lakh | -₹46.3 Lakh | ₹42.8 Lakh | ₹51.5 Lakh | ₹42.8 Lakh |
| Employee Benefit Expense | ₹112.41 Cr | ₹109.01 Cr | ₹99.53 Cr | ₹86.76 Cr | ₹78.32 Cr | ₹55.74 Cr | ₹65.25 Cr |
| Finance Costs | ₹12.78 Cr | ₹11.11 Cr | ₹2.89 Cr | ₹3.1 Cr | ₹2.79 Cr | ₹3.58 Cr | ₹6.36 Cr |
| Depreciation & Amortisation | ₹40.15 Cr | ₹38.89 Cr | ₹37.08 Cr | ₹37.06 Cr | ₹35.5 Cr | ₹36.67 Cr | ₹35.86 Cr |
| Other Expenses | ₹327.57 Cr | ₹380.21 Cr | ₹343.58 Cr | ₹293.59 Cr | ₹270.02 Cr | ₹182.34 Cr | ₹214.27 Cr |
| Total Expenses | ₹806.72 Cr | ₹763.39 Cr | ₹692.07 Cr | ₹606.03 Cr | ₹555.44 Cr | ₹372.79 Cr | ₹444.6 Cr |
| Profit Before Exceptional Items & Tax | ₹116.69 Cr | ₹135.74 Cr | ₹158.31 Cr | ₹121.36 Cr | ₹104.36 Cr | ₹55.49 Cr | ₹57.03 Cr |
| Exceptional Items | -₹69.6 Lakh | ₹0 | ₹0 | ₹0 | -₹4.44 Cr | ₹0 | ₹0 |
| Profit Before Tax | ₹116 Cr | ₹135.74 Cr | ₹158.31 Cr | ₹121.36 Cr | ₹99.92 Cr | ₹55.49 Cr | ₹57.03 Cr |
| Total Tax Expense | ₹3.09 Cr | ₹51.95 Cr | ₹54.47 Cr | ₹40.55 Cr | ₹30.11 Cr | ₹12.61 Cr | ₹29.06 Cr |
| Net Profit | ₹112.91 Cr | ₹83.79 Cr | ₹103.85 Cr | ₹80.81 Cr | ₹69.81 Cr | ₹42.88 Cr | ₹27.97 Cr |
| Other Comprehensive Income | -₹17.3 Lakh | ₹20.3 Lakh | ₹23.09 Lakh | ₹25.5 Lakh | -₹29.3 Lakh | ₹16.5 Lakh | ₹1.7 Lakh |
| Total Comprehensive Income | ₹112.74 Cr | ₹83.99 Cr | ₹104.08 Cr | ₹81.06 Cr | ₹69.51 Cr | ₹43.05 Cr | ₹27.99 Cr |
| EBITDA (computed) | ₹169.62 Cr | ₹185.74 Cr | ₹198.27 Cr | ₹161.52 Cr | ₹142.65 Cr | ₹95.74 Cr | ₹99.25 Cr |
| Basic EPS | ₹10.50 | ₹7.80 | ₹9.68 | ₹7.52 | ₹6.46 | ₹3.97 | ₹2.59 |
| Diluted EPS | ₹10.50 | ₹7.80 | ₹9.67 | ₹7.48 | ₹6.46 | ₹3.97 | ₹2.59 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹1,594.9 Cr | ₹1,469.8 Cr | ₹1,373.99 Cr | ₹1,167.37 Cr |
| Non-current Assets | ₹1,080.56 Cr | ₹994.56 Cr | ₹942.16 Cr | ₹726.03 Cr |
| Current Assets | ₹514.33 Cr | ₹475.24 Cr | ₹431.82 Cr | ₹441.34 Cr |
| Property, Plant & Equipment | ₹605.79 Cr | ₹554.97 Cr | ₹571.68 Cr | ₹587.66 Cr |
| Inventories | ₹24.64 Cr | ₹20.13 Cr | ₹17.48 Cr | ₹19.62 Cr |
| Trade Receivables | ₹179.85 Cr | ₹131.71 Cr | ₹117.71 Cr | ₹89.64 Cr |
| Cash & Equivalents | ₹13.35 Cr | ₹21.6 Cr | ₹9.2 Cr | ₹3.3 Cr |
| Equity (Net Worth) | ₹1,246.94 Cr | ₹1,133.99 Cr | ₹1,062.18 Cr | ₹970.32 Cr |
| Equity Share Capital | ₹107.52 Cr | ₹107.49 Cr | ₹107.41 Cr | ₹107.31 Cr |
| Borrowings (Non-current) | ₹99.53 Cr | ₹85.4 Cr | ₹103.12 Cr | ₹22.07 Cr |
| Borrowings (Current) | ₹20.21 Cr | ₹17.79 Cr | ₹10.91 Cr | ₹12.01 Cr |
| Total Debt (computed) | ₹119.74 Cr | ₹103.19 Cr | ₹114.02 Cr | ₹34.08 Cr |
| Current Liabilities | ₹150.72 Cr | ₹122.29 Cr | ₹108.16 Cr | ₹106.7 Cr |
| Total Liabilities | ₹347.96 Cr | ₹335.81 Cr | ₹311.81 Cr | ₹197.05 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹128.16 Cr | ₹148.82 Cr | ₹139.77 Cr | ₹164.53 Cr | ₹100.98 Cr |
| Investing Cash Flow | -₹108.6 Cr | -₹100.63 Cr | -₹206 Cr | -₹172.4 Cr | -₹40.32 Cr |
| Financing Cash Flow | -₹27.8 Cr | -₹35.8 Cr | ₹72.14 Cr | -₹38.21 Cr | -₹17.25 Cr |
| Capital Expenditure | ₹74.06 Cr | ₹23.09 Cr | ₹31.26 Cr | ₹3.45 Cr | ₹34.67 Cr |
| Free Cash Flow (computed) | ₹54.1 Cr | ₹125.74 Cr | ₹108.51 Cr | ₹161.08 Cr | ₹66.31 Cr |
| Dividends Paid | ₹0 | ₹12.96 Cr | ₹12.86 Cr | ₹10.8 Cr | ₹10.8 Cr |
| Net Change in Cash | -₹8.25 Cr | ₹12.4 Cr | ₹5.91 Cr | -₹46.09 Cr | ₹43.42 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹224.85 Cr | ₹215.24 Cr | ₹223.97 Cr | ₹236.65 Cr | ₹207.06 Cr | ₹220.64 Cr | ₹212.27 Cr | ₹232.72 Cr | ₹206.32 Cr | ₹195.15 Cr | ₹217.09 Cr | ₹211.12 Cr |
| Other Income | ₹5.59 Cr | ₹5.78 Cr | ₹5.81 Cr | ₹5.52 Cr | ₹7.14 Cr | ₹6.28 Cr | ₹5.29 Cr | ₹7.52 Cr | ₹4.37 Cr | ₹5.21 Cr | ₹5.96 Cr | ₹5.26 Cr |
| Total Income | ₹230.45 Cr | ₹221.02 Cr | ₹229.78 Cr | ₹242.18 Cr | ₹214.2 Cr | ₹226.92 Cr | ₹217.56 Cr | ₹240.23 Cr | ₹210.7 Cr | ₹200.36 Cr | ₹223.05 Cr | ₹216.38 Cr |
| Cost of Materials Consumed | ₹75.38 Cr | ₹51.96 Cr | ₹53.46 Cr | ₹0 | ₹53.05 Cr | ₹51.41 Cr | ₹49.95 Cr | ₹0 | ₹49.34 Cr | ₹0 | ₹50.6 Cr | ₹54.76 Cr |
| Purchases of Stock-in-Trade | ₹3.46 Cr | ₹3.57 Cr | ₹3.39 Cr | ₹3.16 Cr | ₹2.88 Cr | ₹2.96 Cr | ₹2.97 Cr | ₹3.01 Cr | ₹2.95 Cr | ₹2.68 Cr | ₹2.65 Cr | ₹2.23 Cr |
| Changes in Inventories | -₹1.3 Lakh | -₹44.3 Lakh | -₹2 Lakh | -₹2 Lakh | ₹12.7 Lakh | -₹1.56 Lakh | -₹5.09 Lakh | -₹10.5 Lakh | -₹19.57 Lakh | -₹9.2 Lakh | -₹20.9 Lakh | ₹10.6 Lakh |
| Employee Benefit Expense | ₹29.39 Cr | ₹28.73 Cr | ₹27.47 Cr | ₹26.82 Cr | ₹26.05 Cr | ₹28.1 Cr | ₹28.97 Cr | ₹27.79 Cr | ₹25.53 Cr | ₹24.76 Cr | ₹24.94 Cr | ₹24.3 Cr |
| Finance Costs | ₹2.36 Cr | ₹3.55 Cr | ₹4.28 Cr | ₹2.58 Cr | ₹2.66 Cr | ₹3.09 Cr | ₹2.7 Cr | ₹2.67 Cr | ₹99.22 Lakh | ₹60.9 Lakh | ₹73.1 Lakh | ₹55.5 Lakh |
| Depreciation & Amortisation | ₹10.53 Cr | ₹10 Cr | ₹9.94 Cr | ₹9.68 Cr | ₹9.63 Cr | ₹9.94 Cr | ₹9.78 Cr | ₹9.54 Cr | ₹9.12 Cr | ₹9.33 Cr | ₹9.43 Cr | ₹9.19 Cr |
| Other Expenses | ₹85.18 Cr | ₹101.78 Cr | ₹100.69 Cr | ₹159.85 Cr | ₹94.12 Cr | ₹95.66 Cr | ₹94.97 Cr | ₹151.5 Cr | ₹90.44 Cr | ₹124.59 Cr | ₹87.59 Cr | ₹85.25 Cr |
| Total Expenses | ₹206.29 Cr | ₹199.14 Cr | ₹199.22 Cr | ₹202.08 Cr | ₹188.52 Cr | ₹191.14 Cr | ₹189.28 Cr | ₹194.4 Cr | ₹178.18 Cr | ₹161.88 Cr | ₹175.72 Cr | ₹176.39 Cr |
| Profit Before Exceptional Items & Tax | ₹24.16 Cr | ₹21.87 Cr | ₹30.56 Cr | ₹40.1 Cr | ₹25.68 Cr | ₹35.77 Cr | ₹28.28 Cr | ₹45.84 Cr | ₹32.52 Cr | ₹38.48 Cr | ₹47.33 Cr | ₹39.99 Cr |
| Exceptional Items | -₹69.6 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹23.46 Cr | ₹21.87 Cr | ₹30.56 Cr | ₹40.1 Cr | ₹25.68 Cr | ₹35.77 Cr | ₹28.28 Cr | ₹45.84 Cr | ₹32.52 Cr | ₹38.48 Cr | ₹47.33 Cr | ₹39.99 Cr |
| Total Tax Expense | -₹30.21 Cr | ₹8.08 Cr | ₹10.81 Cr | ₹14.41 Cr | ₹10.72 Cr | ₹14.91 Cr | ₹10.95 Cr | ₹15.37 Cr | ₹9.96 Cr | ₹13.76 Cr | ₹16.93 Cr | ₹13.82 Cr |
| Net Profit | ₹53.67 Cr | ₹13.79 Cr | ₹19.75 Cr | ₹25.7 Cr | ₹14.96 Cr | ₹20.86 Cr | ₹17.33 Cr | ₹30.47 Cr | ₹22.56 Cr | ₹24.72 Cr | ₹30.39 Cr | ₹26.17 Cr |
| Other Comprehensive Income | -₹2 Lakh | -₹5 Lakh | -₹15.3 Lakh | ₹5.1 Lakh | ₹3.1 Lakh | ₹5.77 Lakh | ₹5.77 Lakh | ₹5.77 Lakh | ₹3.82 Lakh | ₹6.4 Lakh | ₹6.4 Lakh | ₹6.4 Lakh |
| Total Comprehensive Income | ₹53.65 Cr | ₹13.74 Cr | ₹19.6 Cr | ₹25.75 Cr | ₹14.99 Cr | ₹20.92 Cr | ₹17.39 Cr | ₹30.52 Cr | ₹22.6 Cr | ₹24.79 Cr | ₹30.46 Cr | ₹26.23 Cr |
| EBITDA (computed) | ₹37.05 Cr | ₹35.42 Cr | ₹44.78 Cr | ₹52.37 Cr | ₹37.97 Cr | ₹48.8 Cr | ₹40.75 Cr | ₹58.05 Cr | ₹42.63 Cr | ₹48.42 Cr | ₹57.49 Cr | ₹49.73 Cr |
| Basic EPS | ₹4.99 | ₹1.28 | ₹1.84 | ₹2.39 | ₹1.39 | ₹1.94 | ₹1.61 | ₹2.84 | ₹2.10 | ₹2.30 | ₹2.83 | ₹2.44 |
| Diluted EPS | ₹4.99 | ₹1.28 | ₹1.84 | ₹2.39 | ₹1.39 | ₹1.94 | ₹1.61 | ₹2.84 | ₹2.10 | ₹2.30 | ₹2.83 | ₹2.44 |
Shareholding Pattern of Shalby Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 74.33%, foreign institutional investors hold 4.36%, domestic institutional investors hold 0.25%, retail and other public shareholders hold 20.41% of Shalby Limited. The company had 51,415 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 74.33% | 74.33% | 74.33% | 74.27% | 74.27% | 74.27% |
| Public | 25.02% | 25.01% | 25.01% | 25.04% | 25.04% | 25.04% |
| Employee Trusts | 0.66% | 0.66% | 0.66% | 0.69% | 0.69% | 0.69% |
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Promoters | 74.33% | 74.27% | 74.24% | 74.12% | 74.02% | 79.45% | 79.44% | 79.41% | 79.41% |
| Public | 25.02% | 25.04% | 25.01% | 25.01% | 25.05% | 19.62% | 19.63% | 19.65% | 19.64% |
| Employee Trusts | 0.66% | 0.69% | 0.76% | 0.87% | 0.93% | 0.93% | 0.93% | 0.94% | 0.94% |
| Promoter change (YoY, %pts) | +0.06 | +0.03 | +0.12 | +0.10 | -5.43 | +0.01 | +0.03 | +0.00 | - |
Board & Governance of Shalby Limited
As per the corporate governance filing with NSE for the quarter ended 31-DEC-2025, the board of Shalby Limited has 7 directors - 6 independent and 1 executive. The board is chaired by VIKRAM INDRAJIT SHAH.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| VIKRAM INDRAJIT SHAH | Executive Director · MD · Chairperson | 2004-08-30 | 1 |
| SHYAMAL SHIVKUMAR JOSHI | Non-Executive - Independent Director | 2021-05-17 | 1 |
| UMESH KRISHNANKUTTY MENON | Non-Executive - Independent Director | 2016-12-20 | 3 |
| TEJ RAMJIDASS MALHOTRA | Non-Executive - Independent Director | 2017-02-23 | 1 |
| ASHOK BHATIA | Non-Executive - Independent Director | 2023-05-18 | 2 |
| SUJANA MANAN SHAH | Non-Executive - Independent Director | 2018-05-07 | 1 |
| VIJAY KISHANLAL KEDIA | Non-Executive - Independent Director | 2023-05-18 | 2 |
| Committee | Members |
|---|---|
| Audit Committee | UMESH KRISHNANKUTTY MENON (Chairperson), SHYAMAL SHIVKUMAR JOSHI, TEJ RAMJIDASS MALHOTRA, SUJANA MANAN SHAH |
| Nomination and remuneration committee | UMESH KRISHNANKUTTY MENON (Chairperson), SHYAMAL SHIVKUMAR JOSHI, SUJANA MANAN SHAH |
| Stakeholders Relationship Committee | SHYAMAL SHIVKUMAR JOSHI (Chairperson), UMESH KRISHNANKUTTY MENON, VIKRAM INDRAJIT SHAH |
| Risk Management Committee | VIKRAM INDRAJIT SHAH (Chairperson), SHYAMAL SHIVKUMAR JOSHI, SUJANA MANAN SHAH |
| Corporate Social Responsibility Committee | SUJANA MANAN SHAH (Chairperson), SHYAMAL SHIVKUMAR JOSHI, UMESH KRISHNANKUTTY MENON |
Group Structure of Shalby Limited
Shalby Limited has 6 subsidiary companies. This group structure data is as of FY 2023. The corporate group structure reflects Shalby Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Mars Medical Devices Limited | U33100GJ2020PLC113358 | - |
| Slaney Healthcare Private Limited | U33125GJ2008PTC052648 | - |
| Shalby International Limited | U85100GJ2012PLC071824 | - |
| Shalby Hospitals Mumbai Private Limited | U85100GJ2020PTC118765 | - |
| Vrundavan Shalby Hospitals Limited | U85110GA1995PLC001851 | - |
| Yogeshwar Healthcare Limited | U85110GJ1997PLC032486 | - |
Showing major subsidiaries. Total: 6.
Charges & Borrowings of Shalby Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Mar 2025 | Citi Bank N.A. | ₹111.85 Cr | Open |
| 06 Aug 2024 | Hdfc Bank Limited | ₹60 Cr | Open |
| 07 Feb 2023 | Others | ₹170 Cr | Open |
| 17 Dec 2021 | Sbicap Trustee Company Limited | ₹168.53 Cr | Open |
| 14 Oct 2021 | Hdfc Bank Limited | ₹88.72 Lakh | Open |
Total charge records: 45 View all charges
Employees and EPFO Compliance at Shalby Limited
Shalby Limited has a workforce of 2,529 employees as of Apr 07, 2024.
Employee Count & EPFO Data of Shalby Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Shalby Limited
GSTIN & GST Filing Data of Shalby Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Shalby Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Shalby Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Shalby Limited
MSME Payment Delays by Shalby Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Shalby Limited
Subsidiaries & Group Companies of Shalby Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Shalby Limited with ownership details.
MCA Filings & Documents of Shalby Limited
MCA Filings & Documents of Shalby Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Shalby Limited
Recent News on Shalby Limited
Frequently Asked Questions about Shalby Limited
Shalby Limited is an active public limited company in the healthcare sector based in Ahmedabad, Gujarat, India. It was incorporated on 30 August 2004 (22+ years old) and is registered under CIN L85110GJ2004PLC044667. Listed on BSE: 540797 and NSE: SHALBY. The company has 2,529 employees.
Shalby Limited reported revenue of ₹1,114.55 Cr for FY 2025 (up 17.00% YoY).
The current directors of Shalby Limited are:
- Tej Ramjidass Malhotra
- Umesh Krishnankutty Menon
- Ashok Ramprakash Bhatia
- Amit Pathak
- Vikram Indrajit Shah
- Tushar Dineshchandra Shah
- Vijay Kishanlal Kedia
- Tushar Shah
- Shyamal Shivkumar Joshi
- Sujana Manan Shah
- Tushar Dineshchandra Shah
The primary industry of Shalby Limited is healthcare. The company specifically operates in hospitals. The company is currently active in this sector.
Yes. Shalby Limited is listed on both BSE (code: 540797) and NSE (symbol: SHALBY).
Shalby Limited can be reached at the registered office: Opp: Karnawati Club Sarkhej Gandhinagar Highway Nr.Prahladnagar Gardern, Ahmedabad, Gujarat, India – 380015, or through the website shalby.org.